Zobrazeno 1 - 10
of 33
pro vyhledávání: '"SUSIE L. HU"'
Publikováno v:
Kidney Diseases, Vol 7, Iss 2, Pp 90-99 (2021)
Background: Peritonitis is a leading complication of peritoneal dialysis (PD). One strategy that the International Society for Peritoneal Dialysis (ISPD) has used to help mitigate the morbidity and mortality associated with peritonitis is through pre
Externí odkaz:
https://doaj.org/article/310c6099a3da4af89b28abc8e46ef6ea
Publikováno v:
Brown Hospital Medicine. 2
Hydrothorax is an uncommon but established complication of peritoneal dialysis, usually arising from pleuroperitoneal leak. There is currently no consensus on definitive testing or management. Thoracentesis, sclerosing agents, and either temporary or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52a8556bad85ef32e8fd966b005d55a9
https://doi.org/10.56305/001c.57690
https://doi.org/10.56305/001c.57690
Autor:
Matthew R. Lynch, Susie L Hu
Publikováno v:
Journal of Onco-Nephrology. 4:7-14
With increasing prevalence of both kidney disease and cancer, patients who have both are common. Toxicity from treatment or direct kidney injury by the cancer itself can lead to acute kidney injury or progression of pre-existing chronic kidney diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fb8df6c596d13ff7323a8f6b8addb0c
https://doi.org/10.1177/2399369320918256
https://doi.org/10.1177/2399369320918256
Autor:
Susie L. Hu, Ankur Shah
Publikováno v:
Clinical Journal of the American Society of Nephrology. 15:447-449
There has been a recent surge in interest in the interplay between cancer and kidney disease. Both conditions are associated with significant morbidity and mortality; cancer increases risk of kidney disease, and patients with kidney disease have incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25dfc0e6f73ef0c2c5d9aae7264f33b1
https://doi.org/10.2215/cjn.01850220
https://doi.org/10.2215/cjn.01850220
Autor:
Sabrina L. Noyes, Stephen K. Babitz, Adam Bezinque, Jessica Parker, Susie L. Hu, Brian R. Lane
Publikováno v:
Annals of Medicine and Surgery
Background Chronic kidney disease (CKD) staging is improved by adding proteinuria to glomerular filtration rate (GFR). While proteinuria independently predicts CKD progression and mortality, the clinical setting of proteinuria determination has not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5efaf24cff79d1103b5a2bb2622db822
http://europepmc.org/articles/PMC6702410
http://europepmc.org/articles/PMC6702410
Autor:
Sun H Ahn, Susie L. Hu, Eric S Kerns, Nathan Calabro-Kailukaitis, Delin Wang, Mahmoud Mowafy, Khetisuda Suvarnasuddhi, Jonah Licht
Publikováno v:
Clinical Kidney Journal
BackgroundPeritoneal dialysis (PD) is an underutilized modality for hospitalized patients with an urgent need to start renal replacement therapy in the USA. Most patients begin hemodialysis (HD) with a tunneled central venous catheter (CVC).MethodsWe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5add4b1d637b107258a89d97979541a
https://doi.org/10.1093/ckj/sfz053
https://doi.org/10.1093/ckj/sfz053
Publikováno v:
Cureus
End-stage kidney disease (ESKD) patients, including those on peritoneal dialysis (PD), are considered immunocompromised and at risk for opportunistic pathogens. Peritonitis is a major infectious PD complication with common causative pathogens, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b616fbcb85cdf28151a6e4b37703ba
https://doi.org/10.7759/cureus.10564
https://doi.org/10.7759/cureus.10564
Autor:
Susie L. Hu
Publikováno v:
Seminars in nephrology. 40(1)
Renal cell carcinoma is associated with chronic kidney disease as well as with common risk factors including hypertension and diabetes mellitus. Localized renal cell carcinoma is treated surgically and in these cases has a favorable prognosis. In par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9027a03388c46ab331be13453df2c122
https://pubmed.ncbi.nlm.nih.gov/32130967
https://pubmed.ncbi.nlm.nih.gov/32130967
Autor:
Vinay Narasimha Krishna, Jeff Perl, Thomas A. Golper, Matthew J. Oliver, Robert C. Yang, Rachel B. Fissell, Brendan B. McCormick, Scott E. Liebman, Arsh K. Jain, Pietro Ravani, Peter G. Blake, Susie L. Hu, Jenny I. Shen, Rory F. McQuillan, Bethany Pellegrino, Alix Clarke, Robert R. Quinn, James L. Pirkle
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 40(2)
Background: Peritoneal dialysis (PD) is a more cost-effective therapy to treat kidney failure than in-center hemodialysis, but successful therapy requires a functioning PD catheter that causes minimal complications. In 2015, the North American Chapte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fa64a6a0492300f9fdc1dff3133991
https://pubmed.ncbi.nlm.nih.gov/32072874
https://pubmed.ncbi.nlm.nih.gov/32072874
Publikováno v:
Onco-Nephrology ISBN: 9780323549455
This chapter provides an overview of the clinical approach for atypical renal masses and cysts. The excellent survival rates of low stage renal cell carcinoma have resulted in the additional goal of renal function preservation. Chronic kidney disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b89b10fc4d916fede6b359169df09670
https://doi.org/10.1016/b978-0-323-54945-5.00037-0
https://doi.org/10.1016/b978-0-323-54945-5.00037-0
